Clinical trial
The Effects of Finesse on Glycemic Control in Adults With Diabetes Using MDI: Finesse vs. Pen or Syringe and Vial as Bolus Prandial Insulin Device
NCT01073566 is registered in ClinicalTrials.gov with Calibra Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Finesse on Glycemic Control in Adults With Diabetes Using MDI: Finesse vs. Pen or Syringe and Vial as Bolus Prandial Insulin Device
- Lead sponsor
- Calibra Medical, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- July 31, 2010
- Enrollment
- 38 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.